IP Library Granted Patent US 9,221,845
Granted Patent B2
US 9,221,845 · App. 14/645,046 · Granted Dec 29, 2015

Processes and intermediates for making a JAK inhibitor

Inventor: Ganfeng Cao (Newark, DE)
Assignees: Incyte Holdings Corporation; Incyte Corporation
C07F5/04C07D401/14C07D487/04C07F5/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,221,845
App. No.
14/645,046
Granted
Dec 29, 2015
Kind
B2
Abstract

This invention relates to processes and intermediates for making {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, useful in the treatment of diseases related to the activity of Janus kinases (JAK) including inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Claims (49)

1. A compound of Formula VII:

or a salt thereof; wherein:

R 1 and R 2 are each independently H or C 1-6 alkyl; or

R 1 and R 2 , together with the two oxygen atoms to which they are attached and the boron atom to which the oxygen atoms are attached, form a 5- to 6-membered heterocycloalkyl ring, which is optionally substituted with 1, 2, 3, or 4 C 1-4 alkyl groups.

2. The compound of claim 1 , having Formula VIIa:

or a salt thereof.

3. A process, comprising:

reacting a compound of Formula VIII:

with a compound of Formula IX:

in the presence of a coupling agent to form a compound of claim 1 ; wherein:

R 1 and R 2 are each independently H or C 1-6 alkyl; or

R 1 and R 2 , together with the two oxygen atoms to which they are attached and the boron atom to which the oxygen atoms are attached, form a 5- to 6-membered heterocycloalkyl ring, which is optionally substituted with 1, 2, 3, or 4 C 1-4 alkyl groups.

4. The process according to claim 3 , wherein the coupling agent is 1,8-diazabicyclo[5,4,0]undecene.

5. The process according to claim 4 , wherein 1.05 to about 1.2 equivalents of coupling agent is used based on the compound of Formula VIII.

6. The process according to claim 5 , wherein the reacting of the compound of Formula VIII with the compound of Formula IX is conducted in a solvent component comprising acetonitrile.

7. The process according to claim 5 , wherein the reacting of the compound of Formula VIII with the compound of Formula IX is conducted in a solvent component comprising acetonitrile at a temperature of about 40° C. to about 60° C.

8. The process according to claim 7 , wherein 1 to 1.2 equivalents of the compound of Formula IX are used based on the compound of Formula VIII.

9. The process according to claim 3 , wherein the process comprises reacting a compound of Formula VIII:

with a compound of Formula IXa:

in the presence of a coupling agent to form a compound of Formula VIIa:

10. The process according to claim 9 , wherein the coupling agent is 1,8-diazabicyclo[5,4,0]undecene.

11. The process according to claim 10 , wherein 1.05 to about 1.2 equivalents of coupling agent is used based on the compound of Formula VIII.

12. The process according to claim 11 , wherein the reacting of the compound of Formula VIII with the compound of Formula IXa is conducted in a solvent component comprising acetonitrile.

13. The process according to claim 10 , wherein the reacting of the compound of Formula VIII with the compound of Formula IXa is conducted in a solvent component comprising acetonitrile at a temperature of about 40° C. to about 60° C.

14. The process according to claim 13 , wherein 1 to 1.2 equivalents of the compound of Formula IXa are used based on the compound of Formula VIII.

15. The process according to claim 9 , further comprising reacting the compound of Formula VIIa with a compound of Formula IVa:

under Suzuki coupling conditions to form a compound of Formula I:

wherein the Suzuki coupling conditions comprise heating a reaction mixture comprising the compound of Formula VIIa, the compound of Formula IVa, a Suzuki coupling catalyst, a base and a second solvent component.

16. The process according to claim 15 , wherein the catalyst is tetrakis(triphenylphosphine)palladium(0).

17. The process according to claim 16 , wherein the base is sodium bicarbonate.

18. The process according to claim 17 , wherein the sodium bicarbonate is present in 4 equivalents or more based on the compound of Formula VIIa.

19. The process according to claim 18 , wherein the second solvent component comprises 1,4-dioxane and water.

20. The process according to claim 19 , wherein the 1,4-dioxane and water are present in a 1:1 volume ratio.

21. The process according to claim 20 , wherein the compounds of Formula VIIa and IVa are present in about a 1:1 molar ratio.

22. The process according to claim 9 , further comprising reacting the compound of Formula VIIa with a compound of Formula IVa:

under Suzuki coupling conditions to form a compound of Formula I:

wherein the Suzuki coupling conditions comprise heating a reaction mixture comprising the compound of Formula VIIa, the compound of Formula IVa,

tetrakis(triphenylphosphine)palladium(0), sodium bicarbonate, and a second solvent component, wherein the second solvent component comprises water and 1,4-dioxane.

23. A compound of Formula VIII:

or a salt thereof.

24. A process of preparing a compound of claim 23 , or a salt thereof, comprising reacting a compound of Formula VI:

with a compound of Formula X:

or a salt thereof, in the presence of a reducing agent.

25. The process according to claim 24 , wherein the compound of Formula X, or salt thereof, is 2-(azetidin-3-ylidene)acetonitrile hydrochloride.

26. The process according to claim 25 , wherein the reducing agent is sodium cyanoborohydride or sodium triacetoxyborohydride.

27. The process according to claim 25 , wherein the reducing agent is sodium triacetoxyborohydride.

28. The process according to claim 27 , wherein about 1.5 to about 2.5 equivalents of the reducing agent are used based on the compound of Formula X, or salt thereof.

29. The process according to claim 27 , wherein about 2 equivalents of the reducing agent are used based on the compound of Formula X, or salt thereof.

30. The process according to claim 28 , wherein the reacting of the compound of Formula VI and the compound of Formula X, or salt thereof, are conducted in a solvent component comprising dichloromethane.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2015
From: INCYTE CORPORATION
To: INCYTE HOLDINGS CORPORATION; INCYTE CORPORATION
Reel/Frame 036800/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2015
From: LIU, PINGLI; WANG, DENGJIN; WU, YONGZHONG; CAO, GANFENG; XIA, MICHAEL
To: INCYTE CORPORATION
Reel/Frame 035594/0973 →
Continuity (3)
Division 14197701 · Mar 5, 2014
Provisional Application 61773659 · Mar 6, 2013
Related Publication 20150183805A1 · Jul 2, 2015